CD19 and neoplasm: Consistently, the IHC staining of CD19 and MHC class II proteins showed that the number of HLA‐DPB1+ and CD19+ cells were significantly decreased in tumor comparing with adjacent regions (p = .0004, paired Student's t‐test) (Figure 6D,E).